Tarik Y. Farrag, M.D., Ph.D., M.Sc. joins Mint Pharmacy as medical director for our fré line of compounded prescription pain creams.
Farrag brings over 15 years of experience in the surgical management of cancers in the head and neck region, endoscopic skull base surgery, robotic surgery, as well as facial plastics and head and neck reconstructive surgery. His work and accomplishments have earned him recognition in several national and international magazines and newspapers, including Facial Plastic Times, Physicians’ Weekly, ENToday, and others.
Farrag's tendency to confront and resolve challenges attracted him to the very complex areas of the neck and head region and inspired him to seek non-opioid treatments for patients suffering from chronic pain.
"On top of the difficulty of a cancer diagnosis, my patients were struggling with opioid dependency which grew out of their need for relief from chronic pain," said Farrag. "Unfortunately, opioid use for chronic pain creates a whole other set of complications, so I began to investigate a solution that provides strong, effective pain relief without the negative side effects associated with opioids."
According to the National Centers for Disease Control, prescription opioids accounted for 17,029 overdose deaths in the US in 2017.1 An estimated 20.5% or 50 million adults in the US suffer from chronic pain according to a report released by the CDC.2
After finding success with topical pain medicine that is custom-compounded, Farrag partnered with Mint Pharmacy to develop fré, an affordable line of pain creams.
"Topical products can work on several pain-related receptors at once to attack chronic, disabling pain when applied directly on the symptomatic body region while avoiding many disadvantages associated with oral pain products," said Farrag. "I am proud that we can offer our custom-compounded fré formulas to help patients safely return back to a comfortable, functional level."
fré costs $124 for a 3-month supply and includes a medical consultation and custom-based pain management.
Farrag is currently a member of multiple prestigious physician’s societies. He is affiliated with several highly-ranked scientific journals for which he reviews and judges articles and studies submitted by scientists around the world. In addition, his scientific work has involved advanced laboratory research, animal studies, patient clinical trials, as well as the investigation of new treatment modalities while collaborating with the National Institute of Health (NIH) and the Food and Drug Administration (FDA).
He graduated from Johns Hopkins Hospital, Baltimore, MD. While at Hopkins, he authored more than 30 peer-reviewed publications, presented at over 30 national and international conferences, authored numerous textbook chapters, and received several national and international awards for his work. He is proud to have supervised several medical students and junior physicians in training who are now well-accomplished and successful physicians around the nation.
Farrag grew up in an incredibly warm and loving family environment with wonderful and caring parents. His upbringing taught him that most of an individual's value and success in life stems from the services he or she has performed to help others. This had ingrained in him an innate love for helping patients as well as a strong desire to succeed in medicine.
1 Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017. MMWR Morb Mortal Wkly Rep 2019;67:1419–1427. DOI: http://dx.doi.org/10.15585/mmwr.mm675152e1
2 Dahlhamer J, Lucas J, Zelaya, C, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:1001–1006. DOI: http://dx.doi.org/10.15585/mmwr.mm6736a2
Please read our Blog Disclaimer